HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report.

AbstractBACKGROUND:
The COVID-19 is a novel condition affecting all the world, so every manifestation of disease should be reported. Neurologic manifestations of the disease are increasingly identified and this will help clinician to improve their diagnostic and therapeutic skills in dealing with COVID-19 patients.
CASE:
In this article we report a 41-year-old male that developed ascending paresthesia and paralysis following infection with SARS-CoV-2 virus. Electrodiagnostic evaluation in patient revealed demyelinating type polyneuropathy and patient diagnosed as Guillain-Barré syndrome (AIDP type) and treated with IVIG which resulted in favorable response.
CONCLUSIONS:
Considering this report and other reports that are mentioned in our short review, there is probably causal relationship between COVID-19 and development of Guillain-Barré syndrome.
AuthorsMohammad Amin Farzi, Hormoz Ayromlou, Naser Jahanbakhsh, Parisa Hadavi Bavil, Abdolali Janzadeh, Farid Karkon Shayan
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 346 Pg. 577294 (Jun 20 2020) ISSN: 1872-8421 [Electronic] Netherlands
PMID32590125 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: